News
- Author:
- Ted Bosworth
Publish date: March 19, 2023
The recently approved deucravacitinib is the only JAK inhibitor that has so far been exempt from these warnings.
News
- Author:
- Ted Bosworth
Publish date: March 10, 2023
By detecting elevated thoracic fluid levels, a wearable device improves management and outcomes of heart failure.
News
- Author:
- Ted Bosworth
Publish date: March 10, 2023
In an in-hospital anticoagulation trial, the primary COVID endpoint was missed but a survival benefit is observed.
News
- Author:
- Ted Bosworth
Publish date: March 9, 2023
For pulmonary arterial hypertension, a fixed-dose combination of macitentan and tadalafil is safe and effective.
News
- Author:
- Ted Bosworth
Publish date: March 8, 2023
Late lumen loss with a new bioabsorbable drug-eluting stent is on par with nonabsorbable devices in early data.
News
- Author:
- Ted Bosworth
Publish date: March 7, 2023
Long-term blood pressure reductions in the Black patient cohort of the SYMPLICITY renal denervation trial challenge early results.
News
- Author:
- Ted Bosworth
Publish date: March 6, 2023
Causal artificial intelligence is showing how specific risk factors can be overcome to avoid cardiovascular events.
News
- Author:
- Ted Bosworth
Publish date: March 5, 2023
In stent placement for complex coronary lesions, intravascular imaging reduces events relative to angiography.
News
- Author:
- Ted Bosworth
Publish date: March 4, 2023
In a randomized pivotal trial, a percutaneous repair of tricuspid valve regurgitation was effective and safe.
News
- Author:
- Ted Bosworth
Publish date: March 3, 2023
TAVR valves deteriorate less than surgical valves at 5 years in patients treated for severe aortic stenosis.
News
- Author:
- Ted Bosworth
Publish date: March 3, 2023
The systematic review of coronary stent infections leads investigator to question whether they are underreported.
News
- Author:
- Ted Bosworth
Publish date: February 28, 2023
In patients with diabetes and left main artery disease, the risks of PCI and CABG are different when either can be used.
News
- Author:
- Ted Bosworth
Publish date: February 27, 2023
Dietary nitrate in the form of beet juice reduced restenosis after percutaneous interventions in a randomized trial.
News
- Author:
- Ted Bosworth
Publish date: February 16, 2023
A tool to estimate cardiovascular risk in systemic lupus erythematosus incorporates disease-specific variables.
News
- Author:
- Ted Bosworth
Publish date: February 15, 2023
A tool to identify patients with psoriasis at high risk of psoriatic arthritis appears near to clinical application.
